TVP

Investments in US tech and life sciences are made stage-agnostically.

About TVP

It operates on a B2B model.

Company details

Technology Venture Partners functions as a stage-agnostic venture capital firm based in Australia with a focus on US investments. Sectors targeted include technology areas such as cybersecurity and mobile technology, alongside life sciences fields like therapeutics. Operations involve funding startups and established companies across these domains. Portfolio examples encompass Revance Therapeutics, ThreatMetrix, AGY Therapeutics, and Migme, reflecting a commitment to innovative US-based ventures.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Tvp

Premium access

Complete news archive for TVP

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about TVP

Technology Venture Partners functions as a stage-agnostic venture capital firm based in Australia with a focus on US investments. Sectors targeted include technology areas such as cybersecurity and mobile technology, alongside life sciences fields like therapeutics. Operations involve funding startups and established companies across these domains. Portfolio examples encompass Revance Therapeutics, ThreatMetrix, AGY Therapeutics, and Migme, reflecting a commitment to innovative US-based ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available